Reply to comments on "Impact of EUCAST rapid Antimicrobial Susceptibility testing (RAST) on management of Gram-negative bloodstream infection"
- PMID: 36736825
- DOI: 10.1016/j.idnow.2023.104667
Reply to comments on "Impact of EUCAST rapid Antimicrobial Susceptibility testing (RAST) on management of Gram-negative bloodstream infection"
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Comment on "Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection".Infect Dis Now. 2023 Mar;53(2):104668. doi: 10.1016/j.idnow.2023.104668. Epub 2023 Feb 2. Infect Dis Now. 2023. PMID: 36736827 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
